CLYM Climb Bio, Inc.

Fundamentals / CIK 0001768446 / USD

Climb Bio, Inc. reported $236.6M in total assets and a net loss of $59.31M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CLYM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$69.09MFY 2020 Net Income: -$20.67M2020FY 2021 Net Income: -$47.48M2021FY 2022 Net Income: -$45.24M2022FY 2023 Net Income: -$35.12M2023FY 2024 Net Income: -$73.90M2024FY 2025 Net Income: -$59.85M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $46.71M $14.34M $15.41M $26.21M $23.32M $8.77M
Total Operating Expenses $67.88M $82.02M $40.27M $45.13M $35.67M $20.93M
Operating Income -$67.88M -$82.02M -$40.27M -$45.13M -$35.67M -$20.93M
EBITDA -$67.79M -$82.02M -- -- -- --
Interest Income $8.32M $8.13M $4.62M -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$59.85M -$73.90M -$35.12M -$45.24M -$47.48M -$20.67M
Basic EPS -$0.88 -$1.53 -$1.30 -$1.72 -$4.24 -$10.49
Diluted EPS -$0.88 -$1.53 -$1.30 -$1.72 -$4.24 -$10.49
Basic Shares Outstanding 67.8M 48.2M 27.0M 26.3M 12.3M 2.2M
Diluted Shares Outstanding 67.8M 48.2M 27.0M 26.3M 12.3M 2.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $11.04M $9.71M $9.37M $13.74M $9.07M $6.58M $17.33M $5.96M
Total Operating Expenses $16.89M $15.36M $15.21M $19.30M $14.89M $10.68M $23.02M $10.91M
Operating Income -$16.89M -$15.36M -$15.21M -$19.30M -$14.89M -$10.68M -$23.02M -$10.91M
EBITDA -$16.70M -$15.33M -$15.17M -$19.27M -$14.86M -$10.64M -$23.02M --
Interest Income $2.33M $1.85M $1.51M $1.83M $2.04M $2.17M $2.29M --
Income Tax Expense -- -- -- -- -- -- $0 $0
Net Income -$14.57M -$13.50M -$13.72M -$17.52M -$12.89M -$8.67M -$20.78M -$8.42M
Basic EPS -$0.18 -$0.18 -$0.20 -- -$0.19 -$0.13 -$0.31 --
Diluted EPS -$0.18 -$0.18 -$0.20 -- -$0.19 -$0.13 -$0.31 --
Basic Shares Outstanding 80.0M 76.2M 68.2M -- 68.0M 67.6M 67.5M --
Diluted Shares Outstanding 80.0M 76.2M 68.2M -- 68.0M 67.6M 67.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $35.69M $87.23M $93.11M $43.59M $46.92M $20.49M
Short-Term Investments $65.39M $63.69M $13.69M $79.98M $89.56M $0
Cash & Short-Term Investments $160.7M $150.9M $106.8M $123.6M $161.4M $20.49M
Total Current Assets $105.8M $154.9M $110.3M $134.4M $148.3M $22.00M
Property, Plant & Equipment, Net $288K $199K -- -- -- --
Long-Term Investments $59.57M $61.61M $0 $0 $24.92M $0
Other Non-Current Assets $1.53M $16K $15K $128K $70K $2.63M
Total Non-Current Assets $61.90M $62.31M $214K $599K $24.99M $2.63M
Total Assets $167.7M $217.2M $110.5M $135.0M $173.2M $24.63M
Accounts Payable $2.27M $705K $66K $750K $1.40M $1.09M
Other Current Liabilities -- $31K $138K $0 -- --
Total Current Liabilities $6.98M $4.93M $2.83M $6.10M $6.03M $3.06M
Other Non-Current Liabilities -- $0 $22K $0 $7.0K $0
Total Non-Current Liabilities $285K $375K $37K $180K $7.0K $0
Total Liabilities $7.27M $5.31M $2.87M $6.28M $6.04M $3.06M
Total Debt (incl. Leases) $541K $532K $349K $480K -- --
Common Stock $5.0K $7.0K $3.0K $3.0K $3.0K $1.0K
Retained Earnings -$289.7M -$229.9M -$156.0M -$120.9M -$75.62M -$28.14M
Accumulated Other Comp. Income $435K $23K -$2.0K -$358K -$123K $0
Total Stockholders' Equity $160.5M $211.9M $107.6M $128.7M $167.2M -$24.98M
Total Equity $160.5M $211.9M $107.6M $128.7M $167.2M -$24.98M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $39.73M $44.11M $8.36M $35.69M $25.80M $22.68M $29.02M $87.23M
Short-Term Investments $165.7M $139.0M $101.2M $65.39M $61.10M $62.02M $69.04M $63.69M
Cash & Short-Term Investments $205.4M $183.1M $109.6M $160.7M $86.90M $84.70M $98.06M $150.9M
Total Current Assets $210.1M $186.6M $113.4M $105.8M $90.96M $87.38M $100.3M $154.9M
Property, Plant & Equipment, Net $1.33M $695K $250K $288K $318K $314K -- $199K
Long-Term Investments $22.20M $56.10M $36.74M $59.57M $88.93M $102.7M $99.78M $61.61M
Other Non-Current Assets $1.89M $1.65M $1.53M $1.53M $1.53M $1.37M $226K $16K
Total Non-Current Assets $26.41M $59.66M $38.97M $61.90M $91.34M $105.0M $100.5M $62.31M
Total Assets $236.6M $246.3M $152.4M $167.7M $182.3M $192.4M $200.7M $217.2M
Accounts Payable $1.06M $1.13M $860K $2.27M $477K $946K $777K $705K
Other Current Liabilities -- -- -- -- -- -- -- $31K
Total Current Liabilities $7.91M $5.93M $4.07M $6.98M $4.95M $6.21M $7.04M $4.93M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $605K $813K $216K $285K $352K $417K $319K $375K
Total Liabilities $8.51M $6.75M $4.29M $7.27M $5.30M $6.62M $7.36M $5.31M
Total Debt (incl. Leases) $1.07M $1.31M $479K $541K $580K $639K $474K $532K
Common Stock $6.0K $6.0K $5.0K $5.0K $7.0K $7.0K $7.0K $7.0K
Retained Earnings -$331.5M -$316.9M -$303.4M -$289.7M -$272.2M -$259.3M -$250.7M -$229.9M
Accumulated Other Comp. Income -$528K -$67K $157K $435K $469K $318K $286K $23K
Total Stockholders' Equity $228.1M $239.5M $148.1M $160.5M $177.0M $185.8M $193.4M $211.9M
Total Equity $228.1M $239.5M $148.1M $160.5M $177.0M $185.8M $193.4M $211.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$59.85M -$73.90M -$35.12M -$45.24M -$47.48M -$20.67M
Depreciation & Amortization $97K $0 -- -- -- --
Stock-Based Compensation $8.05M $5.56M $12.81M $6.99M $3.74M $707K
Change in Payables $1.56M -$963K -$686K -$653K $318K -$167K
Operating Cash Flow -$54.36M -$15.56M -$20.60M -$37.37M -$36.07M -$14.10M
Capital Expenditure -$186K $0 $0 -- -- --
Free Cash Flow -$54.54M -$15.56M -$20.60M -- -- --
Acquisitions, Net $0 -$4.64M -- -- -- --
Purchases of Investments -$108.1M -$132.2M -$58.45M -$87.96M -$115.0M --
Investing Cash Flow $2.83M -$121.1M $68.98M $34.44M -$115.0M $8.08M
Common Stock Issued -- $10.98M $841K $0 $149K --
Financing Cash Flow -$21K $130.7M $841K $0 $177.2M $4.92M
Net Change in Cash -$51.54M -$5.88M $49.53M -$3.34M $26.43M -$736K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$14.57M -$13.50M -$13.72M -$17.52M -$12.89M -$8.67M -$20.78M -$8.42M
Depreciation & Amortization $195K $33K $38K $30K $29K $38K $0 --
Stock-Based Compensation $2.04M $1.48M $1.60M $1.04M $3.98M $1.01M $2.02M $1.66M
Change in Payables -$67K $200K -$1.41M $1.79M -$393K $93K $72K $414K
Operating Cash Flow -$12.00M -$10.55M -$14.38M -$15.63M -$12.14M -$11.15M -$15.43M -$5.52M
Purchases of Investments -$36.79M -$82.61M -$44.85M -$5.00M -$23.71M -$20.62M -$58.75M -$60.41M
Investing Cash Flow $6.40M -$57.26M -$12.96M $25.54M $15.26M $4.79M -$42.75M -$53.41M
Common Stock Issued -- -- -- -- -- -- $0 $41K
Financing Cash Flow $1.22M $103.7M $5.0K -$21K $0 $0 $0 $41K
Net Change in Cash -$4.38M $35.89M -$27.33M $9.88M $3.12M -$6.34M -$58.21M -$58.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -37.3% -34.9% -32.6% -35.2% -28.4% --
Return on Assets (ROA) -35.7% -34.0% -31.8% -33.5% -27.4% -83.9%
Current Ratio 15.16x 31.41x 38.92x 22.04x 24.58x 7.18x
Quick Ratio 23.01x 30.61x 37.70x 20.27x 26.76x 6.69x
Debt to Equity 0.00x 0.00x 0.00x 0.00x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -26.0% -24.1% -35.6% -37.3% -28.7% -25.2% -48.1% -34.9%
Return on Assets (ROA) -25.1% -23.4% -34.6% -35.7% -27.8% -24.3% -46.3% -34.0%
Current Ratio 26.58x 31.45x 27.86x 15.16x 18.38x 14.08x 14.25x 31.41x
Quick Ratio 25.98x 30.86x 26.91x 23.01x 17.56x 13.65x 13.94x 30.61x
Debt to Equity 0.00x 0.01x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001768446) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal